CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Science With Purpose: Advancing Sustainability In Biopharma Testing

  Learn how biopharma labs are cutting animal use, energy, and paper waste while maintaining GMP compliance — with specific data on 85% labor reductions and 1 ton of CO2e saved annually.

• Control Strategies And Method Development For Nitrosamines In APIs And Drug Products

  Explore regulatory insights, analytical strategies, and real-world case studies for effective nitrosamine control in APIs and drug products.

• Developing CAR T Therapies With A Cell Therapy Manufacturing Platform

  Advances in CAR T cell engineering are expanding clinical potential, but manufacturing complexity limits scale. Integrated, automated workflows offer a path to consistent and efficient production.

• Improved T Cell Expansion Using Closed, Automated Stirred-Tank Bioreactors

  A shift from traditional rocking motion systems to stirred-tank bioreactors can enhance T cell expansion, offering greater scalability and more intimate process control.

• Overcome Patient-Level Access Barriers For New Medicine

  Explore market access from the patient’s perspective and identify five aspects of how people get hold of medicine that should inform commercialization.

• Transforming PSP Enrollment To Enhance User Experiences And Optimize Workflows

  Lengthy enrollment calls burden patients and PSP teams alike. See how a digital-first intake approach cut onboarding time and improved outcomes for everyone involved.

• Negative Stain TEM For Viral Particle Characterization

  Standardized latex bead references combined with negative stain TEM provide precise viral particle characterization and consistent viral load quantification.

• A Faster Path To Genomic Medicine Feasibility

  Life Edit accelerates genomic medicine by comparing five editing modalities, engineering new enzymes, and rapidly pinpointing optimal strategies that boost feasibility, cut risk, and speed clinical progress.

• Flexible Cell Culture Media For High Titer Production Of AAV In HEK 293

  To maximize the results of viral titer and full capsids, it's necessary to undertake systematic process development and optimization of AAV production. The choice of cell culture medium is foundational.

• Handle Single-Use Technology Biopharma Waste: Data Sharing, Collaboration

  Learn more about data sharing and collaboration to enable a better environmental impact of single-use technologies (SUTs) and quantifying the single-use plastic waste generated when manufacturing mAbs.